Reddy S, Wu D, Elliott R B
Department of Paediatrics, University of Auckland School of Medicine, New Zealand.
Autoimmunity. 1995;20(2):83-92. doi: 10.3109/08916939509001931.
Streptozotocin (stz) given in low doses (40 mg/kg body weight) on 5 consecutive days to susceptible strains of mice causes diabetes. Previous studies have shown that the induction of diabetes is associated with inflammatory infiltrates within the pancreatic islets. However, it is unclear whether stz causes limited beta cell destruction followed by insulitis or whether the diabetogen promotes immune cell influx into the pancreatic islets, followed by immune-mediated beta-cell destruction. It is also unclear whether stz given in sub-diabetogenic doses is capable of causing diabetes independent of cell-mediated processes. Here we have examined these possibilities in CB.17 Scid mice which lack functional T and B cells but have immunocompetent macrophages and NK cells. Low dose stz given to Scid mice caused diabetes in approximately 50% of mice of both sexes by 21 days (14/24 males; 10/18 females). Sections of pancreas were examined immunohistochemically for the presence of MAC-1 positive cells (macrophages and natural killer cells) in the exocrine, peri- and intra-islet regions at different time points following the administration of stz. There were no statistically significant differences in the number of immunoreactive cells in the three locations between tissues obtained from stz-injected mice (3, 7, 14 and 21 days after stz injection and at onset of diabetes) and buffer-injected Scid mice. Although diabetic Scid mice showed a reduced number of insulin immunoreactive cells and peri- and intra-islet distributed glucagon cells, no insulitis was seen histochemically. In parallel studies, normal Swiss male mice given stz at a similar dose developed diabetes (10/10) associated with insulitis which consisted predominantly of CD4, CD8 and MAC-1 cells. Balb/c mice given stz similarly, also developed diabetes (5/8) without showing insulitis, although a moderate increase in the number of macrophages were observed within several islets. These studies demonstrate that stz administered in multiple low doses to Scid mice can cause beta cell destruction and diabetes in the absence of immune cell infiltrate within the pancreatic islets.
连续5天给易患糖尿病的小鼠品系低剂量(40毫克/千克体重)的链脲佐菌素(STZ)可导致糖尿病。先前的研究表明,糖尿病的诱发与胰岛内的炎性浸润有关。然而,尚不清楚STZ是导致有限的β细胞破坏继而引发胰岛炎,还是致糖尿病原促进免疫细胞流入胰岛,随后引发免疫介导的β细胞破坏。同样不清楚亚致糖尿病剂量的STZ是否能够独立于细胞介导过程而导致糖尿病。在此,我们在CB.17 Scid小鼠中研究了这些可能性,该小鼠缺乏功能性T细胞和B细胞,但具有免疫活性巨噬细胞和NK细胞。给Scid小鼠低剂量STZ后,到21天时约50%的雌雄小鼠均患糖尿病(14/24只雄性;10/18只雌性)。在注射STZ后的不同时间点,对胰腺切片进行免疫组织化学检查,以检测外分泌、胰岛周围和胰岛内区域中MAC-1阳性细胞(巨噬细胞和自然杀伤细胞)的存在情况。在从注射STZ的小鼠(注射STZ后3、7、14和21天以及糖尿病发病时)获得的组织与注射缓冲液的Scid小鼠的组织之间,三个位置的免疫反应性细胞数量没有统计学上的显著差异。尽管糖尿病Scid小鼠的胰岛素免疫反应性细胞以及胰岛周围和胰岛内分布的胰高血糖素细胞数量减少,但组织化学检查未发现胰岛炎。在平行研究中,给予相似剂量STZ的正常瑞士雄性小鼠患糖尿病(10/10),伴有主要由CD4、CD8和MAC-1细胞组成的胰岛炎。同样给予STZ的Balb/c小鼠也患糖尿病(5/8),未显示胰岛炎,尽管在几个胰岛内观察到巨噬细胞数量有适度增加。这些研究表明,给Scid小鼠多次低剂量施用STZ可在胰岛内无免疫细胞浸润的情况下导致β细胞破坏和糖尿病。